Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The primary objective was to demonstrate a difference between two insulin strategies, one
targeting postprandial (PP) hyperglycemia and the other targeting fasting and interprandial
hyperglycemia, on time until the first combined adjudicated cardiovascular (CV) event
(primary outcome defined as CV death, nonfatal myocardial infarction [MI], nonfatal stroke,
coronary revascularization, or hospitalized acute coronary syndrome).